Guidelines represent a major shift in CVD risk management

New guidelines on preventing cardiovascular disease mean a substantial change in the assessment and management of risk, including a shift away from aiming toward specific LDL targets. The change is a big one for doctors, who have for years worked with patients to manage cholesterol numbers. "If you ask patients, 'Why do you take a statin?' they say 'to lower my cholesterol level,' not 'to lower my cardiovascular risk,'" said internist Dr. Steven Woloshin. But cardiologist Dr. Valentin Fuster points out that in addition to influencing cholesterol levels, statins reduce clotting and inflammation, while drugs whose sole effect is lower LDL levels do not appear to be effective in other areas.

View Full Article in:

New York Times (tiered subscription model), The · New York Times (tiered subscription model), The · Star Tribune (Minneapolis-St. Paul, Minn.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC